 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
By submitting press releases and news to NanoPharmaceuticals.org you will hold NanoPharmaceuticals.org free of
any charges with regards to copyright infringements should the content you provided be copyright protected by third
party.
NanoPharmaceuticals.org is not responsible for the accuracy of the statements made in press releases or news by
companies, PR agencies or individuals quoted in such releases or articles.
NanoPharmaceuticals.org is under no obligation to include press releases or news submitted by companies or their PR
agencies regardless of relevance, nor can NanoPharmaceuticals.org be made responsible to remove or edit stories 72
hours after being posted to our site.
Press releases and news submitted to NanoPharmaceuticals.org may be distributed to 3rd party companies for added
exposure, however NanoPharmaceuticals.org is not under any obligation to do so nor can NanoPharmaceuticals.org be
held responsible if articles are not distributed at all or even in a timely manner.
In no event shall NanoPharmaceuticals.org be liable for any damages whatsoever, and in particular
NanoPharmaceuticals.org shall not be liable for special, indirect, consequential, or incidental damages, or damages for
lost profits, loss of revenue, or loss of use, arising out of or related to the NanoPharmaceuticals.org website or the
information contained in it.
No content on NanoPharmaceuticals.org may be republished in part or in full without the express written consent of
NanoPharmaceuticals.org with the exception of the originating company (or university or individual), or other agents
of their choosing.
If you have any questions regarding these terms and conditions, please contact us
